The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19

摘要

Six Chinese patent medicines played an important role in the three main symptoms during the recovery period of the COVID-19. During the COVID-19 period, due to virus infection, age, the existence of chronic diseases and over treatment, many abnormal symptoms and signs still existed in patients during the recovery period, including cardiopulmonary dysfunction such as pulmonary fibrosis, insomnia caused by anxiety and depression, vomiting, diarrhea and other digestive symptoms. In this regard, we have carried out the “three syndromes and six Chinese patent medicines” project, including Jinshuibao tablet, Shengmaiyin oral liquid could effectively improve cardiopulmonary function, Xiaoyao capsule and Shumian capsule could effectively improve sleep disorders caused by depression and anxiety, Xiangshaliujun pill and ludangshen oral liquid could effectively improve gastrointestinal symptoms such as diarrhea and vomiting.